VanEck Associates’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.3M | Buy |
34,287
+799
| +2% | +$398K | 0.02% | 429 |
|
|
2025
Q4 | $16.3M | Sell |
33,488
-6,172
| -16% | -$2.87M | 0.01% | 440 |
|
|
2025
Q3 | $16.6M | Buy |
39,660
+29,297
| +283% | +$9.85M | 0.02% | 399 |
|
|
2025
Q2 | $2.98M | Sell |
10,363
-84
| -0.8% | -$25.1K | ﹤0.01% | 892 |
|
|
2025
Q1 | $3.22M | Buy |
10,447
+199
| +2% | +$68.2K | ﹤0.01% | 867 |
|
|
2024
Q4 | $3.62M | Sell |
10,248
-508
| -5% | -$187K | ﹤0.01% | 811 |
|
|
2024
Q3 | $3.79M | Sell |
10,756
-138
| -1% | -$46.6K | ﹤0.01% | 746 |
|
|
2024
Q2 | $3.47M | Buy |
10,894
+355
| +3% | +$94K | ﹤0.01% | 707 |
|
|
2024
Q1 | $2.42M | Buy |
10,539
+475
| +5% | +$107K | ﹤0.01% | 807 |
|
|
2023
Q4 | $2.21M | Buy |
10,064
+379
| +4% | +$87.4K | ﹤0.01% | 777 |
|
|
2023
Q3 | $2.19M | Buy |
9,685
+84
| +0.9% | +$19.3K | ﹤0.01% | 731 |
|
|
2023
Q2 | $2.12M | Buy |
9,601
+5,419
| +130% | +$1.2M | ﹤0.01% | 715 |
|
|
2023
Q1 | $937K | Buy |
4,182
+2,642
| +172% | +$651K | ﹤0.01% | 848 |
|
|
2022
Q4 | $428K | Buy |
1,540
+208
| +16% | +$52.5K | ﹤0.01% | 951 |
|
|
2022
Q3 | $279K | Buy |
1,332
+120
| +10% | +$26.8K | ﹤0.01% | 981 |
|
|
2022
Q2 | $286K | Buy |
1,212
+136
| +13% | +$27.6K | ﹤0.01% | 1006 |
|
|
2022
Q1 | $193K | Buy |
1,076
+148
| +16% | +$28.2K | ﹤0.01% | 1104 |
|
|
2021
Q4 | $201K | Buy |
928
+43
| +5% | +$8.44K | ﹤0.01% | 1107 |
|
|
2021
Q3 | $163K | Sell |
885
-3,801
| -81% | -$749K | ﹤0.01% | 1061 |
|
|
2021
Q2 | $841K | Buy |
4,686
+467
| +11% | +$88.9K | ﹤0.01% | 826 |
|
|
2021
Q1 | $706K | Buy |
+4,219
| New | +$703K | ﹤0.01% | 794 |
|
|
2020
Q3 | – | Sell |
-58,177
| Closed | -$7.04M | – | 1036 |
|
|
2020
Q2 | $7.04M | Buy |
58,177
+7,985
| +16% | +$898K | 0.02% | 301 |
|
|
2020
Q1 | $4.76M | Sell |
50,192
-3,577
| -7% | -$340K | 0.02% | 319 |
|
|
2019
Q4 | $4.74M | Buy |
53,769
+4,933
| +10% | +$434K | 0.02% | 378 |
|
|
2019
Q3 | $3.9M | Sell |
48,836
-5,512
| -10% | -$444K | 0.02% | 372 |
|
|
2019
Q2 | $4.24M | Sell |
54,348
-18,676
| -26% | -$1.75M | 0.02% | 360 |
|
|
2019
Q1 | $8.57M | Sell |
73,024
-8,900
| -11% | -$1.04M | 0.04% | 235 |
|
|
2018
Q4 | $8.92M | Sell |
81,924
-735
| -0.9% | -$85.2K | 0.04% | 234 |
|
|
2018
Q3 | $10.6M | Buy |
82,659
+1,367
| +2% | +$169K | 0.05% | 238 |
|
|
2018
Q2 | $9.2M | Buy |
81,292
+17,203
| +27% | +$1.89M | 0.04% | 235 |
|
|
2018
Q1 | $7.2M | Sell |
64,089
-15,294
| -19% | -$1.94M | 0.04% | 263 |
|
|
2017
Q4 | $11.7M | Sell |
79,383
-43,717
| -36% | -$5.56M | 0.06% | 221 |
|
|
2017
Q3 | $14.4M | Buy |
123,100
+10,598
| +9% | +$1.35M | 0.07% | 205 |
|
|
2017
Q2 | $14.6M | Buy |
112,502
+19,120
| +20% | +$2.39M | 0.08% | 194 |
|
|
2017
Q1 | $12.6M | Buy |
93,382
+16,540
| +22% | +$2.51M | 0.06% | 211 |
|
|
2016
Q4 | $11M | Sell |
76,842
-9,672
| -11% | -$1.23M | 0.05% | 208 |
|
|
2016
Q3 | $10.2M | Sell |
86,514
-14,588
| -14% | -$1.75M | 0.05% | 210 |
|
|
2016
Q2 | $10.7M | Sell |
101,102
-14,253
| -12% | -$1.59M | 0.05% | 197 |
|
|
2016
Q1 | $12.9M | Sell |
115,355
-15,141
| -12% | -$1.92M | 0.09% | 153 |
|
|
2015
Q4 | $20.4M | Buy |
130,496
+26,364
| +25% | +$3.84M | 0.16% | 129 |
|
|
2015
Q3 | $13.7M | Sell |
104,132
-20,696
| -17% | -$3.32M | 0.11% | 159 |
|
|
2015
Q2 | $21.7M | Buy |
124,828
+7,802
| +7% | +$1.4M | 0.13% | 142 |
|
|
2015
Q1 | $20.2M | Sell |
117,026
-17,726
| -13% | -$2.7M | 0.12% | 146 |
|
|
2014
Q4 | $17.4M | Buy |
134,752
+27,126
| +25% | +$3.5M | 0.11% | 148 |
|
|
2014
Q3 | $13.8M | Sell |
107,626
-3,517
| -3% | -$363K | 0.07% | 179 |
|
|
2014
Q2 | $9.84M | Sell |
111,143
-26,770
| -19% | -$2.57M | 0.05% | 198 |
|
|
2014
Q1 | $13M | Buy |
137,913
+2,859
| +2% | +$292K | 0.06% | 178 |
|
|
2013
Q4 | $15.3M | Buy |
135,054
+16,676
| +14% | +$1.5M | 0.08% | 148 |
|
|
2013
Q3 | $9.33M | Buy |
118,378
+14,559
| +14% | +$1.06M | 0.05% | 183 |
|
|
2013
Q2 | $6.83M | Buy |
+103,819
| New | +$6.69M | 0.04% | 194 |
|
Other funds holding UTHR
ACA
VPM
VCM
